Showing results (1-10 of 972) with videos related to
Sort By:
Pageof 98
Der Nervenarzt|May 11, 2019
[Challenges and future perspectives in neuro-oncology]Ghazaleh Tabatabai, Michael WellerDiscovery Medicine|June 30, 2011
Stem cell-mediated gene therapies for malignant gliomas: a promising targeted therapeutic approach?Ghazaleh Tabatabai, Wolfgang Wick, Michael WellerCurrent Neurology and Neuroscience Reports|March 20, 2012
Clinical implications of molecular neuropathology and biomarkers for malignant gliomaGhazaleh Tabatabai, Monika Hegi, Roger Stupp, et al.Current Opinion in Neurology|October 25, 2013
Malignant astrocytoma in elderly patients: where do we stand?Ghazaleh Tabatabai, Roger Stupp, Wolfgang Wick, et al.Current Pharmaceutical Design|August 11, 2011
The role of integrins in glioma biology and anti-glioma therapiesGhazaleh Tabatabai, Jorg-Christian Tonn, Roger Stupp, et al.Cases Journal|September 5, 2008
Vertebral artery dissection presenting with ispilateral acute C5 and C6 sensorimotor radiculopathy: A case reportGhazaleh Tabatabai, Wolfgang Schöber, Ulrike Ernemann, et al.Neuro-Oncology|August 29, 2014
Differential regulation of TGF-β-induced, ALK-5-mediated VEGF release by SMAD2/3 versus SMAD1/5/8 signaling in glioblastomaKatharina Seystahl, Isabel Tritschler, Emese Szabo, et al.Brain : a Journal of Neurology|July 13, 2006
Irradiation and hypoxia promote homing of haematopoietic progenitor cells towards gliomas by TGF-beta-dependent HIF-1alpha-mediated induction of CXCL12Ghazaleh Tabatabai, Brigitte Frank, Robert Möhle, et al.Future Oncology (London, England)|October 6, 2010
Should biomarkers be used to design personalized medicine for the treatment of glioblastoma?Michael Weller, Wolfgang Wick, Monika E Hegi, et al.Pageof 98